Trial Profile
Intra assay relative bioavailability of two formulations of tacrolimus: Prograf (normal release tablets) and Advagraf (sustained release tablets) for children transplanted kidney [Ensayo intrapaciente de biodisponibilidad relativa de dos formulaciones de tacrolimus: Prograf (comprimidos de liberación normal) y Advagraf (comprimidos de liberación sostenida) en niños trasplantados de riñón]
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2012
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacogenomic; Pharmacokinetics
- 20 Nov 2012 Planned End Date changed to 24 Dec 2010.
- 14 Jun 2011 New trial record